Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
4(80.0%)
N/A
1(20.0%)
5Total
Phase 4(4)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02610686Phase 4Unknown

Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central Vietnam

Role: lead

NCT02604966Phase 4Unknown

P. Falciparum Resistance to Artemisinin in Vietnam

Role: lead

NCT01379326Phase 4Completed

Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2

Role: collaborator

NCT01775592Phase 4Completed

Plasmodium Falciparum Artemisinin Resistance Vietnam

Role: lead

NCT00853281Not ApplicableCompleted

A Cluster Randomized Trial to Evaluate Long Lasting Insecticidal Hammocks to Prevent Forest Malaria in Vietnam

Role: collaborator

All 5 trials loaded